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Abstract  
Pulmonary rehabilitation (PR) is established as an effective intervention in optimising 
function and quality of life in patients with COPD. However, there is limited data on the 
effectiveness of PR in older patients with COPD.  
 
We reviewed all patients attending an 8 week outpatient programme. Patients were divided 
into two groups; Group A (n=202), below 70 years and Group B (n=122), above 70 years of 
age. Outcomes in both patient subgroups were compared using FEV1, Incremental Shuttle 
Walk Test (ISWT), Endurance Shuttle Walk Test (ESWT), Grip Strength, St. George’s 
Respiratory Questionnaire (SGRQ), Hospital Anxiety and Depression Score (HADS), and 
COPD Assessment Test (CAT) score. Statistical analysis was conducted using Mann-
Whitney non-parametric testing and Chi-squared testing for comparison of clinically relevant 
improvements between groups. 
 
There was no significant difference in PR outcomes between Group A and Group B using 
absolute values. Mean changes for ISWT in Group A and B 39.7m vs. 32.8m (p=0.63) 
respectively, SGRQ -2.5 vs. -2.8 (p=0.95), HADS anxiety score -0.83 vs. -0.57 (p=0.43) and 
HADS depression score -0.69 vs. -0.39 (p=0.48) respectively. There was no difference in the 
proportion of patients who achieved the minimally clinically significant improvement in 
Group A versus Group B in for parameters ISWT (38.6% vs 42.7%), SGRQ (27.8% vs 
21.3%), HADS total score (20.5% vs 28.1%). 
 
These data suggest that benefits of PR in COPD are not age dependent. Age should not be a 
barrier to enrolling patients with COPD in PR programmes. 
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ABBREVIATIONS: COPD=chronic obstructive pulmonary disease, PR = pulmonary 
rehabilitation, BMI = body mass index, FEV1 = forced expiratory volume in one second, 
ISWT= incremental shuttle walk test, ESWT = endurance shuttle walk test, SGRQ = St. 
George’s Respiratory Questionnaire, HADS = hospital anxiety and depression score, CAT = 
COPD assessment test, HRQoL = health related quality of life, mMRC = Modified Medical 
Research Council score, MCID = minimal clinically important difference, ADL = activities 
of daily living. 
 
Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is associated with increased morbidity and 
mortality worldwide. It is the fourth leading cause of death worldwide and is predicted to be 
the third most common cause of death by 2020 [1]. In Ireland, COPD has an estimated 
prevalence of 400,000 people from a population
 
of 4.58 million and according to the 
INHALE report
 
[2]. The prevalence of COPD is increasing in older age groups [3]. In the 
context of an ageing population, it is evident that health burden of COPD and its co-
morbidities will continue to increase and exert a major impact on health services 
internationally [2,4].
  
Pulmonary rehabilitation (PR) plays a crucial role in the care of COPD 
patients and has been shown to reduce improve exercise and functional capacity and reduce 
exacerbations [1,5,6,7].  Many studies have established the effectiveness of PR in improving 
exercise tolerance, health related quality of life (HRQoL) as well as reducing dyspnoea, 
exacerbations and hospitalisations
 
[8-11].
   
The effectiveness of PR in older patients with 
COPD has been examined in a number of small studies however, it has not been convincingly 
demonstrated that older patients respond as well to PR as younger patients [12-15].  The aim 
of this study was to compare the efficacy of PR in a large cohort of COPD patients above and 
below the age of seventy years. 
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Methods  
A retrospective review was performed on all patients with a confirmed diagnosis of 
COPD, who completed a 8 week, 16 session, outpatient PR programme over 6 years between 
2008 and 2014. This was an outpatient programme based in a local community hospital with 
gym and educational facilities. Patients were referred to the PR programme through the 
outpatient service of the Department of Respiratory Medicine, Cork University Hospital by 
the lead physician for COPD and PR (MTH). Patients were only excluded if they could not 
access the facility for logistical reasons or were deemed neurologically or cardiologically 
unsuitable for an outpatient PR programme.  Individually prescribed exercise programmes 
were designed for patients by an experienced COPD physiotherapist and nurse specialist. Full 
physiological assessments took place before and immediately after completion of the PR 
programme. Sixteen educational sessions were provided by the consultant respiratory 
physician, respiratory physiotherapist and COPD nurse specialist, social worker, professional 
smoking cessation counsellor and clinical psychologist.  
The patients were divided into two groups; Group A below the age of 70 and Group 
B, above 70 years. Patient demographics and PR outcomes were collected from the 
programme database. Outcome measures analysed were forced expiratory volume in one 
second (FEV1), Incremental Shuttle Walk Test (ISWT) distance, Endurance Shuttle Walk 
Test (ESWT) time, Grip Strength, St. George's Respiratory Questionnaire (SGRQ) and 
Hospital Anxiety and Depression Score (HADS), Modified Medical Research Council 
(mMRC) and CAT  (COPD assessment test) scores. Data was analysed using SPSS V.21. 
The efficacy of PR was assessed by comparing the differences in the evaluated parameters 
between the two groups. Mann-Whitney U test and Chi-squared test were used to evaluate 
changes in parameters post-programme by age group in three ways, in keeping with 
Page 4 of 25
URL: http:/mc.manuscriptcentral.com/copd
COPD: Journal Of Chronic Obstructive Pulmonary Disease
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
approaches used in previous studies; change in mean raw measures as illustrated in table 2, 
mean % change from baseline in table 3 and proportion of patients achieving minimally 
clinical significant improvement.   For some parameters the dataset was incomplete and this 
is reflected in the results tables below.  Both Mann-Whitney U and Chi –squared testing were 
also used to determine whether there was a significant difference between groups defined by 
clinically significant change [16]
 
in ISWT, SGRQ, HADS and CAT corrected for their 
baseline mean BMI, (dividing the patient cohort into those with BMI < 20 versus those ≤ 20), 
FEV1 (those < 1 L/s versus those ≥ 1 L/s) and CAT score (those with CAT score < 20 versus 
those with a score ≥ 20). P-values of less than 0.05 were considered statistically significant 
throughout.
 
This study was approved by the clinical research ethics committee (CREC) of the 
Cork University Hospitals.   
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Results 
 
A total of 324 COPD patients attending the PR programme were analysed, of whom 122 
patients were 70 years of age or above. In Group A, the mean (SD) age was 61 (3.79) years 
while in Group B was 75 (6.9) years. Patients’ mean baseline characteristics are shown in 
Table 1.  Table 2 shows the mean change in raw measures post PR programme by age group. 
Mann Whitney U testing showed that there was no significant differences in the changes 
achieved between the younger Group A patients and the older Group B patients.  Table 3 
illustrates the % change in parameters post-programme in order to take into account the 
differences in baseline parameters between the groups. Again, no significant differences 
between age groups were found.  
We also compared the proportion of patients achieving clinically significant improvement in 
parameters between age groups using a Chi squared test.  Parameters examined were ISWT – 
(MCID 47.5M) [17], total SGRQ score (MCID -4) [18], total HADS score (MCID 1.5) [19] 
and CAT score (MCID 2).  There is no universally accepted MCID for grip strength.
 
38.6% of patients in group A and 42.7% of patients in group B achieved a MCID in ISWT 
distance walked post PR programme. This difference was not significant between groups.  
27.8% of patients in group A and 21.3% in group B achieved MCID in SGRQ score post 
programme. This difference was not significant between groups.  20.5% of patients in group 
A and 28.1% of patients in group B achieved a MCID in HAD score post PR programme. 
This difference was not significant between groups. Finally, 26.5% of group A patients and 
25.9% of patients in group B achieved MCID in CAT scores post PR programme and again 
there was no significant difference between groups.  Overall taking into account all 3 
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parameters, 56.2% patients in Group A and 51.4% of patients in Group B achieved an MCID 
in at least one of the 3 parameters measured and there was no significant difference between 
groups.  
 
When we attempted to control for patient cohort baseline FEV1, CAT score and BMI to 
determine if these baseline parameters were associated with better outcomes from PR across 
the group (table 4) as a whole and in both the younger and older patient cohorts we found the 
following: The numbers with low BMI (<18.5) were very small (n=8) and thus the data was 
insufficient for comparison.  Using both Mann U Whitney (p=0.007) and Chi squared 
analysis (p=0.003), a lower FEV1 (<1 L/s)  pre-programme (at baseline) was associated with 
a clinically significant improvement in HADS score across the whole population over the 
course of the PR program. Those with lower FEV1 were found to be most likely to gain 
improvement in both anxiety and depression scores.  This relationship was found to be age 
independent, baseline FEV1 <1 L/s versus HADS improvement in Group A (p=0.011) was 
matched by the improvement in HADS in the low FEV1 in Group B (P=0.017). 
In contrast in Group A, under 70 year old COPD patients, those who achieved with a 
clinically significant improvement of >2 points in CAT score had a higher FEV1 at baseline 
(≥1 L/s), (p=0.01). Looking at baseline CATS scores to define predictors of response we 
found the following: A lower baseline CAT is linked to clinically significant change in CAT 
across age groups.  A lower baseline CAT (<20) was linked to clinically significant change in 
ISWT in Group B (>70 years) but not in Group A, however, a lower baseline CAT (<20) was 
linked to clinically significant change in SGRQ Group A but not in Group B. 
Those who achieved a clinically significant improvement in ISWT had a lower CAT score 
(<20) at baseline in Group B (p=0.007, Mann U Whitney, p=0.014 Chi squared).  In Group 
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A, this relationship was significant using comparison of means (p=0.01) but not by Chi 
squared test.  
A low CAT score at baseline did not predict improvement of SGRQ scores in Group B, but 
did predict improvement in SQRG in the younger Group A (p=0.01 Mann U Whitney, p=0.05 
Chi squared) 
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Discussion 
 
The efficacy of PR is well recognised as a therapeutic intervention in COPD patients; 
however, the benefits amongst older patients remain unclear. Our data suggest that COPD 
patients over the age of 70 years benefit from a comprehensive outpatient PR programme to a 
similar extent to their younger counterparts under 70 years.  
 
COPD is a growing problem in the older patients and is often undertreated. [20] Some 
previous PR studies, have excluded patients over the age of seventy. [21,22] It is apparent PR 
has sometimes been considered inappropriate for older patients because of the physiological 
effects of ageing which would limit their ability to take part or improve their exercise 
capacity. The justification for age exclusion remains ambiguous, nevertheless patients over 
the age of 70 years are frequently excluded along with patients with other co-morbidities such 
as ischaemic heart disease, heart failure or and arthritis.
.
 [22,23] Furthermore, clinical trials 
commonly use the age seventy as the lower limit for patient recruitment based on the 
consideration that those between the age of 65 and 70 years have a general health status that 
is good enough to benefit from therapeutic interventions that are often used in younger 
patients. [24]
 
We chose a threshold of seventy years for our study to test the hypothesis that 
age should not be a barrier to the benefits of PR in COPD.  There are data in the literature 
that older patients and older patients with severe COPD benefit from PR. Couser et al 
compared the effects of inpatient and outpatient pulmonary rehabilitation on old older 
patients COPD patients (aged 75 years or over) and younger subjects.[12]
  
The data from this 
study suggest that 6-month comprehensive outpatient PR programmes are as beneficial in 
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older patients with severe or very severe COPD as they are in younger. The authors suggested 
that patients with seriously impaired lung function and major exercise limitation   (n=150 
patients, 17 patients over age 75 years with severe COPD) could benefit from a 6-month 
ambulatory multidisciplinary PR programme, although they often have significant co-
morbidities. Adherence levels and benefits of older patients with COPD to this long duration 
comprehensive programme were in the same range as those seen younger patients. 
 
One of the strengths of our study was the large sample size of 324 patients and the long time 
frame of 6 years over which the data was compiled compared to other studies conducted in 
similar area. Katsura demonstrated that Pulmonary rehabilitation is an effective treatment in 
terms of improving dyspnoea, exercise capacity and HRQoL in older COPD patients, and the 
benefits are almost comparable for young-older patients and old-older patients patients. 
However, this was a small study (n=59) and a 2 week programme. [13]
  
Our study involves a 
much larger cohort over 8 weeks and with patient numbers in both groups, allowing for a 
high quality analysis to be carried out. Roomi et al assessed the effects of incremental 
pulmonary rehabilitation for 12 weeks on older patients COPD patients over 70 years of age. 
In a limited small cohort, they showed a significant increase in exercise capacity on the 
6MWD. [25]
 
Our study, which has the largest described cohort to date of older patients, 
showed that both patient groups demonstrate comparable improvements in functional and 
quality of life scores, with a majority of patients exceeding MCID thresholds in measured 
clinical parameters in both groups. 
 
The main limitation in this study is that it is retrospective and we do not have extensive 
follow up data on long term patient outcomes and compliance with exercise post programme. 
We have a large patient cohort and an 8 week, 16 session programme, however the data 
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collection though comprehensive, was not complete. Some baseline parameters, such as the 
body mass index, blood pressure and other co-morbidities were not measured. These details 
could have made the study more informative; to assess their impact on patients’ performance 
post PR. Interviewer bias should also be taken into consideration. Apart from that, there was 
no control for both groups, but it would have been unethical to refuse PR to these COPD 
patients who remain symptomatic.   
 
From a functional aspect, both patient groups in this study had a negligible difference in their 
lung function after PR. There was a relatively equal mean improvement seen across all 
parameters in both groups following rehabilitation, with the exception of FEV1.   This is 
similar to other studies which have shown that PR does not have a discernible effect on the 
FEV1
 
[8,10] confirming that that the benefits of PR are in improvements in patients’ quality 
of life and functionality rather than demonstrable improvements in pulmonary physiology.  
 
The ISWT distance increased by 25% (39.7m) in Group A and 43% (32.8) in Group B albeit 
from a lower baseline after PR. The older patients group did not attain an improvement that 
would indicate a significant clinical response. However, as ISWT reflects the domestic 
functional capacity of an individual, any positive change in exercise performance should be 
considered as beneficial to the patient. [17]
 
The same improvement in walk distance gain can 
have a very different clinical meaning depending upon the baseline performance: a 70-m gain 
may in fact provide either a negligible or substantial effect of the functional improvement 
depending upon whether baseline walk distance was 250m or 100 m. Indeed, there is a strong 
association between the walk distance and the level of independence in basic and 
instrumental activities of daily living (ADLs). A comprehensive 12-week outpatient PR 
programme has been shown to increase both 6 minute walk distance and activities of daily 
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living. [26]
 
Relatively small improvements in walk distance in older patients who naturally 
have a lower baseline walk distance may correspond to very clinically relevant improvements 
in ADLs and personal independence, even allowing for modest real improvements as in the 
case in our study. Similarly, a severe limitation in physical capabilities should not be a reason 
for excluding older patients COPD patients from a PR programme; rather these patients may 
achieve the greatest benefit. [15]
  
A strength of this study is that we recorded both ISWT and ESWT in our patient cohort. 
Pepin et al validated the ESWR in terms of improvements perceived by patients. A change in 
endurance shuttle walking performance of 45 - 85 s (or 60-115m) after bronchodilation is 
likely to be perceived by patients. [27] Improvements of 78s and 68s in Groups A and B 
respectively are almost certainly going to be perceived as beneficial in our study. Again there 
was no significant difference between groups and the same argument likely applies as to why 
there is a slightly smaller improvement in the older group who had a lower baseline. This 
should not detract the very significant clinically important that both groups achieved after PR 
with older patients performing as well as their younger counterparts. In the field of COPD 
research, MID values have usually been reported as fixed values, expressed in the unit of the 
instrument. When one takes age into account, perhaps MID estimates should be expressed as 
a fraction of the baseline values. [28,29]
 
 
We have no MCID for grip strength from literature. Our PR program spent considerable time 
with patients working on upper limb strength and flexibility. This was reflected in 
improvements in grip strength in both right and left hands in both group A and B. In our 
cohort improvement in grip strength also showed no statistically significant difference 
between the groups. However it is notable that the relative improvements are larger in the 
older group who again, not unsurprisingly, started from a lower baseline. The improvement 
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was slightly higher in the right hand which is most likely accounted by the fact that a higher 
proportion of people favour their right hand.    
 
PR has also been shown to improve patients’ HRQoL and we analysed this using the SGRQ 
and HADS scores. A reduction of 4 units in SGRQ is considered to be the MCID. [16,18] 
Reductions in SGRQ were similar between the two groups, 2.5 in Group A and 2.8 in Group 
B. As for the HADS total score (MCID -1.5 units), Group A attained a larger reduction of 
0.8, in comparison to Group B with 0.5 reduction. [19] Nonetheless, there was no statistically 
significant difference between the outcomes in both groups. When the HADS domains were 
assessed individually, depression scores dropped more than the anxiety scores in both groups. 
This is consistent with earlier studies. [9,10] This may be explained by the improved 
functional capacity that uplifts one’s spirits and changes their outlook on life. The social 
aspect of the programme also builds healthy interactions and motivations that may contribute 
to this positive outcome. It is interesting that in both groups, those with a lower baseline 
FEV1 benefitted most in terms of improvement in HADS score with PR, suggesting that in 
fact regardless of age, those with more severe COPD may derive most benefit in mood and 
disease related anxiety. Similarly those with more severe disease reflected by a low 
programme CAT score derived the most significant improvement in CAT score with PR 
indicating again that regardless of age, disease severity should not be a barrier to participation 
in a comprehensive PR programme.
 
 
 
Conclusion  
In summary, our study suggests that PR is beneficial in both young and older patients COPD 
patients, although trending slightly better in the younger cohort. Thus, age alone should not 
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be a limiting factor to participate in a PR programme as any improvement should be patients 
of all age groups should be encouraged to enrol in this programme as it does have a role in 
improving health outcomes. 
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Table 1: Baseline characteristics (mean value) of the two groups of COPD patients 
 Mean pre-programme parameters (SD) by age group 
 
 
Total n=324 <70 year (n=202) >/= 70 years (n=122) 
 
 
  n  n Mann Whitney U 
Test  
Age  
 
61.5 (6.9) 202 75.5 (3.9) 122 N 
BMI  
 
28.5 (6.6) 190 27.8 (6.2) 117 NS 
FEV1 (l/s) 
 
1.37 (0.59) 196 1.24 (0.49) 117 NS 
ISWT  (m) 
 
232.3 (132) 200 151 (108) 122 p<0.001 
ESWT  (s) 
 
341 (321) 194 219 (225) 119 p<0.001 
SGRQ Total 
 
51.8 (16.6) 157 52.2 (15.5) 82 NS 
HADS – A  
 
8 (4.3) 198 6.3 (3.8) 122 p<0.001 
HADS – D  
 
5.9 (3.6) 198 5.3 (3.2) 122 NS 
Right Grip (kg) 
 
25.5 (10.6) 195 22.4 (9.8) 118 P<0.05 
Left Grip (kg)   
   
23.8 (10.1) 199 20.4 (8.9) 119 P<0.01 
mMRC  
 
1.47 (1.06) 123 1.39 (0.96) 71 NS 
CAT 
  
21.8 (7.6) 133 19.8 (7.7) 82 NS 
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Table 2 shows the mean change in raw measures post PR programme by age group. Mann 
Whitney U testing showed that there was no significant differences in the changes achieved 
between the younger Group A patients and the older Group B patients.   
 
 Mean change in raw parameters (SD) by age group 
 
 
 < 70 years 
(n=202) 
 
n >70 years 
(n=122) 
 
n Mann Whitney 
U Test 
FEV1 (l/s) -0.003(0.2) 
 
123 0.003 (0.24) 82 NS 
ISWT  (m) 39.7 (71.7) 
 
127 32.8 (62.4) 89 NS 
ESWT (s) 78.4 (353) 
 
123 68.4 (206.5) 87 NS 
SGRQ Total -2.5 (10.1) 
 
97 -2.8 (10.5) 61 NS 
HADS – A -0.8 (2.6) 
 
126 -0.5 (3.4) 89 NS 
HADS – D -0.6 (2.3) 
 
126 -0.3 (2.4) 88 NS 
Right Grip (kg) 1.6 (4) 
 
129 1.2 (4.2) 86 NS 
Left Grip  (kg) 1.4 (4.2) 
 
128 1.1 (3.6) 87 NS 
mMRC -0.2 (1.1) 
 
77 -0.02 (1.4) 52 NS 
CAT -1.8 (6.0) 
 
83 -1.7 (6.6) 58 NS 
 
 
Page 23 of 25
URL: http:/mc.manuscriptcentral.com/copd
COPD: Journal Of Chronic Obstructive Pulmonary Disease
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Table 3 illustrates the % change in parameters post-programme in order to take into account 
the differences in baseline parameters between the groups. Again, no significant differences 
between age groups were found.  
 
 Mean % change in parameters (SD) by age group 
 
 
 < 70 years 
(n=202) 
n >70 years 
(n=122) 
 
n Mann Whitney 
U Test 
FEV1 
 
0.5 (16) 123 -0.6 (15) 82 NS 
ISWT 25.4 (51.5) 127 43.6 (100) 
 
89 NS 
ESWT 49.7 (106) 123 47.2 (97.6) 
 
87 NS 
SGRQ Total 
 
-1 (34.6) 97 -6 (23.3) 61 NS 
HADS – A -0.36 (67.9) 126 
 
13.1 (109. 85 NS 
HADS – D 0.5 (73.2) 126 
 
9.8 (73.4) 88 NS 
Right Grip 11.9 (27.1) 129 22.7 (75.2) 
 
86 NS 
Left Grip 9.7 (28.5) 
 
128 13 (48) 87 NS 
mMRC -0 (73) 77 16.9 (110.2) 
 
51 NS 
CAT -4.4 (38.1) 83 
 
-4.8 (43.3) 58 NS 
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Table 4: The association between baseline characteristics FEV1 (Forced Expiratory Volume 
in 1 sec), BMI (Basal Metabolic Index) and CAT (COPD Assessment Test) 
 
 
 Group A (<70 years) Group B (>70 years) 
Baseline BMI Numbers too small for analysis 
 
Baseline FEV1 FEV1 <1L  associated with: 
      clinically significant change         
      in HADS 
 
FEV1> 1L associated with clinically 
significant change in CAT 
 
FEV1 <1L  associated with: clinically 
significant change in HADS 
Baseline CAT Lower baseline CAT associated 
  with: 
  clinically significant change in  
  CAT 
 
  clinically significant change in        
  ISWT (Mann Whitney only) 
 
  clinically significant change in  
  SGRQ 
Lower baseline CAT associated 
  with: 
  clinically significant change in 
  CAT 
 
  clinically significant change in  
  ISWT 
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